ATE186210T1 - Heterofunktionelle mucoadhäsive galenische zusammensetzung - Google Patents

Heterofunktionelle mucoadhäsive galenische zusammensetzung

Info

Publication number
ATE186210T1
ATE186210T1 AT95916694T AT95916694T ATE186210T1 AT E186210 T1 ATE186210 T1 AT E186210T1 AT 95916694 T AT95916694 T AT 95916694T AT 95916694 T AT95916694 T AT 95916694T AT E186210 T1 ATE186210 T1 AT E186210T1
Authority
AT
Austria
Prior art keywords
mucoadhesive
pct
layer
heterofunctional
active principle
Prior art date
Application number
AT95916694T
Other languages
English (en)
Inventor
Norbert Emile Bromet
Original Assignee
Biotec Centre Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Centre Sa filed Critical Biotec Centre Sa
Application granted granted Critical
Publication of ATE186210T1 publication Critical patent/ATE186210T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
AT95916694T 1994-04-01 1995-03-31 Heterofunktionelle mucoadhäsive galenische zusammensetzung ATE186210T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403895A FR2718020B1 (fr) 1994-04-01 1994-04-01 Composition galénique mucoadhésive hétérofonctionnelle.

Publications (1)

Publication Number Publication Date
ATE186210T1 true ATE186210T1 (de) 1999-11-15

Family

ID=9461682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916694T ATE186210T1 (de) 1994-04-01 1995-03-31 Heterofunktionelle mucoadhäsive galenische zusammensetzung

Country Status (8)

Country Link
US (1) US5879710A (de)
EP (1) EP0754033B1 (de)
JP (1) JP4083215B2 (de)
AT (1) ATE186210T1 (de)
CA (1) CA2186863A1 (de)
DE (1) DE69513157D1 (de)
FR (1) FR2718020B1 (de)
WO (1) WO1995026713A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001037814A1 (en) * 1999-11-23 2001-05-31 Robert Gordon University Bilayered buccal tablets comprising nicotine
US6458384B2 (en) 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
IT1318524B1 (it) * 2000-05-17 2003-08-27 Ambros Pharma S R L Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
US20030194420A1 (en) * 2002-04-11 2003-10-16 Richard Holl Process for loading a drug delivery device
US20050053558A1 (en) * 2003-03-18 2005-03-10 Arthur Zuckerman Sleep inducing toothpaste made with natural herbs and a natural hormone
US8679484B2 (en) 2005-03-02 2014-03-25 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
EP2361081B1 (de) * 2008-10-14 2016-06-29 McNeil AB Aus mehreren portionen bestehende intraorale dosierform und ihre verwendung
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
EP2233134A1 (de) 2009-03-27 2010-09-29 McNeil AB Mehrteilige intraorale Darreichungsform mit organoleptischen Eigenschaften
BRPI1012170A2 (pt) * 2009-05-20 2016-03-29 Lingual Consegna Pty Ltd formulação e/ou sublingual e método para reduzir a quantidade de composto ativo usado para alcançar um efeito em um paciente em comparação com um composto típico que é ingerido.
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
ITMI20110332A1 (it) * 2011-03-03 2012-09-04 Ambros Pharma S R L Formulazioni contenenti melatonina a rilascio pulsatile o sequenziale e procedimento per la loro preparazione
EP2570126B1 (de) 2011-09-16 2014-03-26 Darius Rassoulian Verwendung von Melatonin zur Behandlung akuter Alkoholvergiftung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4470846A (en) * 1981-05-19 1984-09-11 Alcan International Limited Removal of alkali metals and alkaline earth metals from molten aluminum
US4740365A (en) * 1984-04-09 1988-04-26 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
ATE135905T1 (de) * 1989-11-03 1996-04-15 Riker Laboratories Inc Bioadhäsive zusammensetzung und pflaster
DK0518468T3 (da) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatoninholdige sammensætninger

Also Published As

Publication number Publication date
JPH09510986A (ja) 1997-11-04
DE69513157D1 (de) 1999-12-09
WO1995026713A1 (fr) 1995-10-12
CA2186863A1 (fr) 1995-10-12
EP0754033B1 (de) 1999-11-03
FR2718020A1 (fr) 1995-10-06
EP0754033A1 (de) 1997-01-22
JP4083215B2 (ja) 2008-04-30
US5879710A (en) 1999-03-09
FR2718020B1 (fr) 1996-05-31

Similar Documents

Publication Publication Date Title
ATE186210T1 (de) Heterofunktionelle mucoadhäsive galenische zusammensetzung
MX9307885A (es) Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
ES2172654T3 (es) Uso de nsaid para el tratamiento de carcinomas de celulas escamosas de la cavidad oral u orofaringe.
DE69432076D1 (de) Neue pharmazeutische formulierungen
ITMI922192A1 (it) Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
SE9600072D0 (sv) New oral formulation of two active ingredients II
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
FI963567A (fi) Diklofenakki-Na:a sisältävä depottabletti
ES2176331T3 (es) Uso de agentes inmunosupresores para el tratamiento de la esquizofrenia.
SE9502219D0 (sv) Novel medical use
GR3030954T3 (en) Children-proof package for active substance-containing plaster
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NZ241234A (en) Amino polyhydroxy cyclohexane derivatives and medicaments
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
NO952308L (no) Anvendelse av ruluzoler som radiorestaurator

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties